key: cord-0929784-l57i2ndn
authors: Liu, Nianping; Jiang, Chen; Cai, Pengfei; Shen, Zhuoqiao; Sun, Wujianan; Xu, Hao; Fang, Minghao; Yao, Xinfeng; Zhu, Lin; Gao, Xuyuan; Fang, Jingwen; Lin, Jun; Guo, Chuang; Qu, Kun
title: Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
date: 2021-09-17
journal: Cell Rep
DOI: 10.1016/j.celrep.2021.109793
sha: 0f6fb0066bed584fece36e620fda62cf5bccba82
doc_id: 929784
cord_uid: l57i2ndn

The mortality risk of coronavirus disease 2019 (COVID-19) patients has been linked to the cytokine storm caused by SARS-CoV-2. Understanding the inflammatory responses shared between COVID-19 and other infectious diseases that feature cytokine storms may therefore help in developing improved therapeutic strategies. Here, we use integrative analysis of single-cell transcriptomes to characterize the inflammatory signatures of peripheral blood mononuclear cells from patients with COVID-19, sepsis, and HIV infection. We identify ten hyperinflammatory cell subtypes in which monocytes are the main contributors to the transcriptional differences in these infections. Monocytes from COVID-19 patients share hyperinflammatory signatures with HIV infection and immunosuppressive signatures with sepsis. Finally, we construct a “three-stage” model of heterogeneity among COVID-19 patients, related to the hyperinflammatory and immunosuppressive signatures in monocytes. Our study thus reveals cellular and molecular insights about inflammatory responses to SARS-CoV-2 infection and provides therapeutic guidance to improve treatments for subsets of COVID-19 patients.

Sepsis is a disease syndrome with high mortality; a comprehensive report estimated that 61 J o u r n a l P r e -p r o o f 8

To characterize the inflammatory responses of patients with these three infectious diseases, we 138 defined an inflammatory score for each cell according to its expression of literature-supported 139 cytokines and a set of inflammatory response-related genes (Table S2) . A total of ten cell 140 subtypes were defined as hyperinflammatory cells (see Methods for details), including five 141 monocyte subtypes, three T cell subtypes, one neutrophil subtype, and one megakaryocyte 142 subtype ( Figure 2A and Figure S3A ). UMAP analysis showed that the inflammatory score was 143 obviously elevated in monocytes of COVID-19 and HIV patients compared to healthy donors, 144 excepting a small proportion of neutrophils ( Figure 2B ). In contrast, little change in 145 inflammatory score was observed in the sepsis samples ( Figure 2B) . 146

This analysis supports that monocytes may be a major source of cytokine storms, as reported in 147 previous studies (Guo et al., 2020; Zhou et al., 2020) . Consistently, canonical proinflammatory 148 cytokines were highly expressed in monocytes of patients compared to other cell subtypes 149 ( Figure 2C ). IL1B and IL6 showed the highest expression levels in HIV patients, followed by 150 COVID-19, with the lowest levels in sepsis patients. To further explore inflammatory responses, 151 we conducted unsupervised hierarchical clustering by applying relative gene expression changes 152 against the healthy donors in these hyperinflammatory cell subtypes ( Figure 2D , see Methods for 153 details). The hyperinflammatory cell subtypes were clustered together according to disease, 154 rather than cell type ( Figure 2D , Figure S3B ), findings similar to the results of an integrated 155 analysis of COVID-19 and influenza infection patients (Lee et al., 2020) . 156 We also used Gene Ontology (GO) analysis to investigate disease-specific and shared 9 chemokine receptor genes (i.e., CXCR4, TRAF1, IFNGR1) and nuclear transcription factors (i.e., 160 NFKB1, RUNX1, XBP1) were specifically upregulated in COVID-19. Leukemia inhibitory factor 161 (LIF) is known to play an important role in cytokine storms in the lungs during pneumonia 162 (Foronjy et al., 2014; Quinton et al., 2012) , and we found that the response to the LIF pathway 163 was specifically enriched in PBMCs in COVID-19 patients. STAT1, IFI30, and class I HLA 164 genes were specifically upregulated in HIV infection. Genes encoding ubiquinone 165 oxidoreductase subunits were specifically upregulated in sepsis. In addition, ISG15, ISG20, IFI6, 166 IL1B, and TNF, genes that are involved in the defense response to viruses and the type I 167 interferon signaling pathway, were upregulated in both COVID-19 and HIV infection. We conducted weighted gene correlation network analysis (WGCNA) to further identify the 175 contribution of each cell type to each disease at the molecular level and identified four gene 176 modules (GMs) ( Figure 2F , Table S3 ). We found that T cell subtypes shared a common gene 177 module (GM2) ( Figure 2F ). CCL5, CSF1R, S100A8, and IFITM3 were modularized in T cell 178 subtypes of all three diseases (GM2, Figure 2F ), and were involved in T cell proliferation and 179 various cytokine-mediated cell pathways ( Figure S3C ). Interestingly, we found three disease-180 specific gene modules (GM1; GM3; GM4), all of which showed that the greatest portion of 181 variation compared to healthy donors were concentrated in the inflammatory monocyte subtypes 182 10 ( Figure 2F , Figure S3D ). Specifically, in the COVID-19 group, TNFSF13B, IRAK2 and APP, 183 which function in cytokine-mediated signaling and platelet degranulation, were modularized in 184 monocytes (GM1, Figure 2F ). In the sepsis group, GRN, SRP14, and CSTB, which are involved 185 in mitochondrial ATP synthesis and oxidative phosphorylation, were modularized in monocytes 186 (GM4, Figure 2F ). In the HIV infection group, ISG15, IFI30, IFI6, IFIT1, JAK2, and STAT1, 187 which have functions related to the interferon response and viral genome replication, were 188 modularized in monocytes (GM3, Figure 2F ). 189

These results imply that monocytes are the cell type responsible for the greatest portion of the 190 differences in immune responses among these diseases, while T cells may play a common role in 191 host responses to all of these infections. We also observed consistent patterns of cytokine gene 192 expression in these diseases. In monocytes, TNFSF13, PDGFA and TNFSF13B were highly 193 expressed in COVID-19. FTH1, IL18, and S100A12 were highly expressed in sepsis. OSM, 194 CCL4, TNF, CXCL3, and IL1RN were highly expressed in HIV infection ( Figure S3E , see 195

Methods for details). Thus, distinct cytokines are secreted by monocytes in response to these 196 infections, which may serve as hallmarks of these infectious diseases. In total, we identified ten 197 hyperinflammatory cell subtypes, and the differences in inflammatory responses among these 198 three infections was dominated by monocytes. We identified seven clusters of monocytes, namely, Mono-CD14-CCL3, Mono-CD14-HLA, 203

Mono-CD14-S100A8-RETN, Mono-CD14-S100A8-CD163, Mono-CD14-IFITM3, Mono-204 CD14-CD16 and Mono-CD16 ( Figure 1B ). To further dissect the immune signatures in 205 monocytes among COVID-19, sepsis, and HIV patients, we conducted differential expression 206 analysis and Gene Ontology enrichment analysis to identify the DEGs and biological functions 207 of these seven monocyte subtypes. Notably, Mono-CD14-IFITM3 and Mono-CD14-CD16 are 208 two monocyte subtypes specific to COVID-19 patients ( Figure 1D ) that initiate interferon 209 signaling in response to infection ( Figure S4A ). Both Mono-CD14-HLA and Mono-CD16 210 expressed high levels of MHC class II molecules (HLA-DRA, HLA-DRB1 and HLA-DQB1, 211 Figure 3A ). However, Mono-CD14-HLA was simultaneously enriched in three diseases, whereas 212

Mono-CD16 was enriched in sepsis and HIV but depleted in COVID-19 patients ( Figure 1D ). 213

We found that the antigen processing and presentation pathways and cellular response to IFN-γ 214 were enriched in Mono-CD14-HLA ( Figure S4A ). This suggested that the Mono-CD14-HLA 215 subtype apparently represents a "classical monocyte subtype" that is normally activated in 216 response to infection. 217

Mono-CD14-CCL3 is marked by high expression of the proinflammatory cytokines IL1B 218 and CCL3, which may be reminiscent of cytokine storm-correlated monocytes in COVID-19 219 (Guo et al., 2020) . Consistent with this conjecture, Mono-CD14-CCL3 is significantly enriched 220 in cytokine-mediated signaling pathways ( Figure S4A ). We also found that the proportion of 221

Mono-CD14-CCL3 cells was significantly increased in COVID-19 and HIV patients ( Figure  222 S4B). To uncover the potential immune features of Mono-CD14-CCL3 across the three diseases, 223 we performed pairwise differential expression analysis in samples from different states of 224 COVID-19, sepsis, HIV, and healthy donors. We characterized five disease-specific and cross-225 disease gene signatures using k-means clustering in Mono-CD14-CCL3 cells ( Figure 3B ). DEGs 226 in C2 (shared between COVID-19 and HIV) included the proinflammatory cytokines TNF and 227 IL1B and chemokines CCL3 and CXCL3, which have been reported to be correlated with 228 12 cytokine storms in COVID-19 patients (Guo et al., 2020; Huang et al., 2020) . Further GO 229 analysis indicated that the DEGs in C2 exhibited significant enrichment for cytokine-mediated 230 signaling pathways and type I interferon responses ( Figure S4C ). Although these results showed 231 that Mono-CD14-CCL3 was associated with cytokine storms, inflammatory cytokines were 232 expressed differently in the three diseases ( Figure 3C ): the sepsis samples did not show high 233 levels of proinflammatory cytokine, chemokine or ISG expression compared to healthy donors. 234

Thus, we identified Mono-CD14-CCL3 as a specific monocyte state that may contribute to 235 cytokine storms in COVID-19 and HIV patients. 236

Mono-CD14-S100A8-CD163 and Mono-CD14-S100A8-RETN were marked by ALOX5AP 237 and RETN, genes which have been linked to immunosuppressive MS1 monocytes in sepsis 238 (Reyes et al., 2020a) . We found that Mono-CD14-S100A8-CD163 and Mono-CD14-S100A8-239 RETN significantly expressed gene signatures derived from MS1-like monocytes (Reyes et al., 240 2020a) and presented low expression of MHC class II genes ( Figure S4D ), which are considered 241 to be anergic in sepsis (Venet et al.) . Therefore, we defined Mono-CD14-S100A8-CD163 and 242

Mono-CD14-S100A8-RETN as MS1-like monocytes. Furthermore, we found that the proportion 243 of MS1-like monocytes was elevated in COVID-19 and sepsis patients compared with healthy 244 donors ( Figure S4E ). 245

Similar to the pairwise differential expression analysis in Mono-CD14-CCL3 cells, we 246 obtained six gene signatures in MS1-like monocytes ( Figure 3D ). DEGs in C3 was shared 247 between COVID-19 and sepsis and showed high expression of calprotectin-encoding genes 248 (S100A8, S100A9), RETN COVID-19 disease, and we visualized the COVID-19 patient samples into a trajectory. Each 300 patient sample was reduced to a single dot, and the dots were aligned (by the pseudo-stage) 301 within identified clusters. 302

We identified three clusters (Cluster 1, Cluster 2, and Cluster 3) of samples from 303 individuals with different disease states along the pseudo-stage, and detected clear differences in 304 the inflammatory responses of these clusters ( Figure 4B ). We then developed a "three-stage 305 model" for understanding the state of monocyte-mediated inflammatory responses in these 306 different groups of patients that is directly based on the subtype proportions and differentially 307 expressed genes of our data from Cluster 1, Cluster 2, and Cluster 3. We found that the 308 composition of different clusters presented a diverse distribution ( Figure 4B ). Specifically, 309

Cluster 1 was mainly composed of samples from healthy donors and convalescent patients; 310

Cluster 2 contained most of the samples from convalescent patients and a minority of samples 311 from patients with active disease, while Cluster 3 was mainly the samples of patients with severe 312 active disease ( Figure 4B ). Notably, samples in Cluster 3 were significantly enriched in 313 inflammation-related genes, such as IL1B, TNF, and CCL3 ( Figure S6A ). These results indicated 314 that peripheral inflammation is quite heterogeneous amongst COVID-19 patients. 315

Next, we analyzed the composition of immune cells in the three clusters and found distinct 316 enrichment of different cell subtypes. The T-CD4-LTB-S100A4 subtype was enriched in Cluster 317 1 samples; two MS1-like monocyte subtypes (Mono-CD14-S100A8-CD163 and Mono-CD14-318 S100A8-RETN) were enriched in Cluster 2 samples; and megakaryocytes and Mono-CD14-319 J o u r n a l P r e -p r o o f 16 CCL3 were highly enriched in Cluster 3 samples ( Figure 4C ). These results suggested that the 320 difference in inflammation levels in patients may be caused by differential abundance of certain 321 immune cell subtypes. To further explore the relationship between these immune cell subtypes 322 and clusters of samples from patients, we compared the expression of the identified marker genes 323 of these cell subtypes among samples from the Clusters 1-3. We found that samples from Cluster 324 2 had the highest expression of MS1-like monocyte markers, while samples from Cluster 3 325 overexpressed markers of Mono-CD14-CCL3 ( Figure S6B ). These findings indicated that the 326 clusters of COVID-19 samples represents three informative stages (three-stage) reflecting 327 distinct monocyte inflammatory signatures. 328

To further probe the heterogeneity of the inflammatory response in patients with severe active 329 disease, we first compared the cellular composition and expression of inflammatory markers in 330

Mono-CD14-CCL3 and MS1-like monocytes of samples from three clusters. We found that 331

Cluster 3 had the highest inflammatory level and the highest proportion of the Mono-CD14-332 CCL3 subtype. In contrast, the proportion and expression of the signatures of two MS1-like 333 subtypes (Mono-CD14-S100A8-CD163 and Mono-CD14-S100A8-RETN) were elevated in 334 samples from patients with severe active disease in Cluster 2. Cluster 1 showed no enrichment in 335 the signatures or proportions of these monocytes ( Figure 4D ). 336

We then performed DEG analysis and Gene Ontology enrichment analysis to reveal the 337 molecular factors and pathways which may help differentiate Clusters 1-3. We noticed 338 enrichment for T cell functional pathways associated with adaptive immune response to infection 339 were enriched in patients of Cluster 1, sepsis-associated terms including complement and 340 coagulation cascades were activated in Cluster 2 patients and inflammatory genes and processes 341 were overexpressed in severe patients from Cluster 3 ( Figure S6C ). In addition, IL6, IL1B, CCL3, 342 and other factors, which are involved in several inflammatory responses, were upregulated in 343 patients from Cluster 3 ( Figure 4E ), suggesting inflammation. Genes associated with 344 immunosuppression in sepsis, such as S100A8, S100A9, SLC30A1, IL18, RETN reanalyze the data reported in this paper is available from the lead contact upon request. 532

Before integrating the datasets collected from different pieces of literature and cohorts, a series 536 of preprocessing steps were performed. We first filtered out cells with fewer than 500 detected 537 genes. We also removed potential doublets using Scrublet (Wolock et al., 2019) . We ran the 538 typical Scrublet workflow to calculate the doublet scores and score threshold using the default 539 parameters except that expected_doublet_rate was set to 0.08. Then (Table S2 ). The inflammatory score was calculated with the built-in function 558 "scanpy.tl.score_genes" in Scanpy. We performed the Mann-Whitney rank test (single-tailed, 559 greater) for the scores of each pair of cell subtypes. Ten cell subtypes (T-CD4-FOS, T-CD4-560 LTB-S100A4, T-CD8-SLC4A10, Mega, Mono-CD14-CCL3, Mono-CD14-HLA, Mono-CD14-561 S100A8-RETN, Mono-CD14-S100A8-CD163, Mono-CD16, Neu) were defined as 562 hyperinflammation-associated clusters with statistical significance (P-value < 0.0001) in all three 563 infectious diseases. 564 565

To identify the DEGs in different clusters or disease states, we performed differential expression 567 analysis using the built-in function "scanpy.tl.rank_genes_groups" in scnapy and then screened 568 the DEGs with the following thresholds (exceptional cases are explained separately): fold change 569 ≥2, P-value ≤0.01 and fraction of cells expressing the genes in both clusters >10%. In Figure 3B  570 and Figure 3C , pairwise comparisons of HIV (hyperacute, acute), sepsis (cohort 1, cohort 2), 571 COVID-19 (moderate, severe), and healthy donors were performed for Mono-CD14-CCL3 and 572 MS1-like monocytes, respectively. Then, we utilized the k-means clustering algorithm to 573 determine the relative average gene expression of DEGs to identify the gene signatures. 574 575

Briefly, we performed GO analysis using Enrichr (Kuleshov et al., 2016) . As proposed in a 577 previous study (Lee et al., 2020) , in Figure 2E , the hyperinflammatory cell subtypes in COVID-578 19, sepsis, and HIV were separately compared to the same cell subtypes in healthy donors. The 579

DEGs of the hyperinflammatory cell subtypes in each disease were combined. Then, the 580 "common up" or "common down" gene sets at the disease level were defined by intersecting the 581 upregulated or downregulated DEGs for COVID-19, sepsis, and HIV. Figure S4A 

To explore the dynamics of regulon activity during the transition of monocytes, we applied the 616 SCENIC (Aibar et al., 2017) algorithm to these cells of two trajectory paths. We built a 617 coexpression network to target TFs with the R package GENIE3. DNA motif analysis was 618 performed with RcisTarget, after which each cell was scored by AUCell. 619 620

We applied unbiased methods (Ren et al., 2021) to develop a workflow to uncover the 622 heterogeneity of inflammation in COVID-19 patients. Since we identified ten hyperinflammatory 623 cell subtypes that may contribute significantly to inflammatory heterogeneity, our analysis 624 focused on these cell subtypes. We first merged the cells by calculating the average gene 625 expression for each sample (samples with less than 1000 cells were filtered). Then, we calculated 626 the variable genes in each dataset, counted the frequency of the variable genes across datasets, 627 and selected the top 2000 genes for downstream analysis. We further performed principal 628 component analysis (PCA) for dimensionality reduction and applied mutual nearest neighbor 629 (MNN) analyses to eliminate the potential batch effects among datasets (Haghverdi et al., 2018) . 630

We utilized the Leiden clustering method to cluster samples of COVID-19 patients and applied 631 reversed graph embedding (RGE) to uncover the potential pseudostages to link the clusters of 632 patients, which were originally proposed to unveil complicated trajectories in single cells (Qiu et 633 al., 2017) . 634

We re-analyzed another recently published single-cell transcriptome of PBMCs from COVID-19 637 patients. We downloaded the h5ad file with clustering annotation from 638 https://covid19cellatlas.org/. we used the ingest function in scanpy (Wolf et al., 2018) to project 639 the cell annotations in this study to the unannotated data based on the PCA embeddings. 640

DEGs between conditions in this study were calculated with the Wilcoxon rank-sum test (two-642 tailed). In Figure S3A , significance was evaluated by the Mann-Whitney rank test (single-tailed, 643 greater). In Figure S4B , the Mann-Whitney rank test (single-tailed, greater (left) or less (right)) 644 was conducted to assess the significance of gene signatures. In Figure S4C , the Wilcoxon rank-645 sum test was utilized to identify the significance of cell subtype proportion shifts among states in 646 each cell type. For all box plots in Figure 4 and Figure 6 , Student's t-test was applied to evaluate 647 the significance of differences between conditions. In Figure S2 , the significance of cell type 648 composition shifts between disease states and healthy donors was calculated by the Wilcoxon 649 rank-sum test (two-tailed). 650 Table S1 . Clinical characteristics of COVID-19, sepsis and HIV infection samples. Related to 652 0  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27   B   CD3D  CD3E  CD8A  TRDV2  GNLY  NKG7  TYROBP  MKI67  MS4A1  CD79A  CD79B  XBP1  CST3  LYZ  FCER1A  CD1C  LILRA4  ITGAX  CSF3R  PF4 T-CD4-LEF1  T-CD4-FOS  T-CD4-LTB-S100A4  T-CD4-FOXP3  T-CD8-LEF1  T-CD8-GZMK  T-CD8-SLC4A10  T-CD8-ZNF683  T-gdT-TRDV2  NK-TYROBP-CD52  NK-TYROBP- PCC neutrophil activation involved in immune response neutrophil degranulation neutrophil activation neutrophil mediated immunity ATP synthesis coupled electron transport mitochondrial ATP synthesis coupled electron transport cellular respiration oxidative phosphorylation electron transport chain respiratory electron transport chain platelet degranulation T cell activation alpha−beta T cell activation leukocyte cell−cell adhesion lymphocyte differentiation T cell differentiation positive regulation of T cell activation antigen processing and presentation platelet aggregation antigen processing and presentation of exogenous peptide antigen antigen processing and presentation of exogenous antigen antigen processing and presentation of peptide antigen positive regulation of response to wounding regulation of response to wounding blood coagulation coagulation hemostasis mitochondrial respiratory chain complex assembly mitochondrial electron transport, NADH to ubiquinone energy derivation by oxidation of organic compounds cellular response to leukemia inhibitory factor response to leukemia inhibitory factor response to steroid hormone RNA transport nucleic acid transport establishment of RNA localization regulation of response to cytokine stimulus positive regulation of DNA−binding transcription factor activity regulation of cytokine−mediated signaling pathway positive regulation of reactive oxygen species metabolic process regulation of innate immune response regulation of response to biotic stimulus antigen processing and presentation of endogenous peptide antigen via MHC class I antigen processing and presentation of endogenous peptide antigen antigen processing and presentation of peptide antigen via MHC class I regulation of RNA splicing antigen processing and presentation of exogenous peptide antigen via MHC class I cellular response to interferon−gamma interferon−gamma−mediated signaling pathway response to interferon−gamma cellular response to type I interferon type I interferon signaling pathway response to type I interferon negative regulation of viral genome replication negative regulation of viral process negative regulation of viral life cycle regulation of viral process regulation of interspecies interactions between organisms response to virus defense response to virus actin filament organization regulation of actin filament−based process regulation of apoptotic signaling pathway regulation of actin cytoskeleton organization ARF4  IL1R2  CD163  THBS1   TIMM8B  CTSD  UQCRQ  NDUFB7  COX17  COX7C  EIF3J  SNRPG  PGK1  IL10RA  IRF1  SELL  ISG20  HLA- COX8A  COX4I1  COX17  COX7A2  COX5B  COX7C  COX6B1   IFNGR2  HMOX1  IRF2  MYD88  TLR2  IL17RA  IFI35  TYK2   OAS1  OSA2  OAS3  NFKBIA  TNF  IL1B  CCL4  CXCL3   BAX  ATP6V1F  ATP6V1G1  ATP6V0B  IDH2  ID3B  NDUFA3  NDUFS3  SLC25A3   CD86  IFNAR2 EIF2S1  FLNA  DYNLL1  SCYL2   IFI27  IFITM3  TNFSF13B  ZNF688  ISG15  PDGFA   IL1R2  CD163  VCAN  ALOX5AP  RETN  S100A8  S100A12  THBS1  CD83  NFKBIA  CCL3  IL1B 

-CD4-LEF1 T-CD4-FOS T-CD4-LTB-S100A4 T-CD4-FOXP3 T-CD8-LEF1 T-CD8-GZMK T-CD8-SLC4A10 T-CD8-ZNF683 T-gdT-TRDV2 NK-TYROBP-CD52 NK-TYROBP-FCER1G NK-ZNF688-RNF213 MKI67 lymphocytes B-TCL1A B-AIM2 plasma plasma-MKI67 Mono-CD14-CCL3 Mono-CD14-HLA Mono-CD14-S100A8-RETN Mono-CD14-S100A8-CD163 Mono-CD14-IFITM3 Mono-CD14-CD16 Mono−CD16 DC-CD1C DC-LILRA4 Neu MegaF T-CD4-FOS T-CD4-LTB-S100A4 T-CD8-SLC4A10 Mono-CD14-CCL3 Mono-CD14-HLA Mono-CD14-S100A8-RETN Mono-CD14-S100A8-CD163 Mono−CD16

SCENIC: single-cell regulatory 662 network inference and clustering

Systems biological assessment of immunity to 665 mild versus severe COVID-19 infection in humans

Cytokine profiles as markers of disease 668 severity in sepsis: a multiplex analysis

COVID-19: towards understanding of pathogenesis

Clinical and immunological features of severe and moderate 673 coronavirus disease 2019

A distinct innate immune signature marks 676 progression from mild to severe COVID-19

The single-cell landscape of 678 immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome 679 coronavirus 2

An inflammatory cytokine 682 signature predicts COVID-19 severity and survival

Leukemia inhibitory factor 684 protects the lung during respiratory syncytial viral infection

Cytokines and T-Cell Homeostasis in HIV Infection

Metal transporter Slc39a10 regulates susceptibility to inflammatory stimuli by 689 controlling macrophage survival

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Enhancement of CIITA 695 transcriptional function by ubiquitin

Tocilizumab in patients with severe 698 COVID-19: a retrospective cohort study

Single-cell analysis of two severe COVID-19 patients reveals a monocyte-701 associated and tocilizumab-responding cytokine storm

Batch effects in single

RNA-sequencing data are corrected by matching mutual nearest neighbors

Immunosuppression in sepsis: a novel 706 understanding of the disorder and a new therapeutic approach

Sepsis-induced immunosuppression: from 708 cellular dysfunctions to immunotherapy

The cytokine storm and COVID-19

Clinical features of patients infected with 2019 novel coronavirus in 713 Wuhan

COVID-19 cytokine storm: the interplay between 715 inflammation and coagulation

Integrated single-cell analysis of 718 multicellular immune dynamics during hyperacute HIV-1 infection

Variability of Mitochondrial 720 Respiration in Relation to Sepsis-Induced Multiple Organ Dysfunction

Fast, sensitive and accurate integration of single-724 cell data with Harmony

Cytokine 726 Levels in Critically Ill Patients With COVID-19 and Other Conditions

Peripheral Blood Mononuclear Cells Demonstrate Mitochondrial Damage Clearance During 730 Sepsis

Enrichr: a 733 comprehensive gene set enrichment analysis web server 2016 update

WGCNA: an R package for weighted correlation 736 network analysis

Immunophenotyping of COVID-19 and influenza highlights the role of 739 type I interferons in development of severe COVID-19

The Molecular Signatures Database Hallmark Gene Set Collection

Role of Oxidative Stress and 743

Mitochondrial Dysfunction in Sepsis and Potential Therapies

Deep immune profiling of 747 COVID-19 patients reveals distinct immunotypes with therapeutic implications

Visualizing structure and transitions in high-750 dimensional biological data

Association between the cytokine 753 storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection

Genetic mechanisms of critical 757 illness in COVID-19

Immunotherapy -a potential new way 759 forward in the treatment of sepsis

SARS-CoV-2: a storm is raging

Reversed graph embedding resolves complex single-cell trajectories

Leukemia inhibitory factor signaling is required for lung protection during pneumonia

Immunotherapies for COVID-19: 769 lessons learned from sepsis

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

An immune-cell signature of 775 bacterial sepsis

Induction of a regulatory myeloid 778 program in bacterial sepsis and severe COVID-19. bioRxiv

The enigma of sepsis

Global, regional, and national sepsis 784 incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study

Cytokines in Sepsis: Potent 787 Immunoregulators and Potential Therapeutic Targets-An Updated View

Biochemical mechanisms of HIV induced T cell apoptosis

Characterization of cell fate probabilities in single-cell data with Palantir

Elevated Calprotectin and Abnormal Myeloid 799 Cell Subsets Discriminate Severe from Mild COVID-19

Induction of a Striking Systemic Cytokine 802 Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in 803 Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

Single-cell multi-omics 807 analysis of the immune response in COVID-19

Efficacy of Tocilizumab in 810 Patients Hospitalized with Covid-19

Integrative single-cell analysis

Multi-Omics Resolves a Sharp Disease-State Shift between Mild 814 and Moderate COVID-19

The trinity of COVID-19: 816 immunity, inflammation and intervention

Distinct biomarker signatures in HIV acute infection 819 associate with viral dynamics and reservoir size

Immune suppression in the early stage of COVID-19 disease

Inflammation and Mortality in HIV-Infected Adults: Analysis of 824 the FRAM Study Cohort

Myeloid cells in sepsis-acquired 826 immunodeficiency

Immune cell profiling of COVID-19 patients in the recovery stage by 829 single-cell sequencing

A single-cell atlas of the peripheral 832 immune response in patients with severe COVID-19

SCANPY: large-scale single-cell gene 834 expression data analysis

Scrublet: Computational Identification of Cell 836 Doublets in Single-Cell Transcriptomic Data

Clinical characteristics of 82 cases of death from COVID-19

Potential therapy strategy: targeting 840 mitochondrial dysfunction in sepsis

Single-cell landscape of immunological responses in patients with 843 COVID-19

Pathogenic T-cells and inflammatory monocytes incite 846 inflammatory storms in severe COVID-19 patients

Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune 849 Response Landscapes of COVID-19 and Influenza Patients